EGFR expression in vulvar cancer: Clinical implications and tumor heterogeneity

Human Pathology

Volumn 45, Issue 5, 2014, Pages 917-925

  De Melo Maia, Beatriz ^a   Fontes, Adriana Mazega ^a   Lavorato Rocha, André Mourão ^a   Rodrigues, Iara Sant'Ana ^a   De Brot, Louise ^a   Baiocchi, Glauco ^a   Stiepcich, Monica Maria ^b   Soares, Fernando Augusto ^a   Rocha, Rafael Malagoli ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b Fleury   (Brazil)

Author keywords

EGFR; FISH; Immunohistochemistry; Prognosis; Vulvar carcinoma

Indexed keywords

EGFR; FISH; IMMUNOHISTOCHEMISTRY; PROGNOSIS; VULVAR CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA COPY NUMBER VARIATIONS; FEMALE; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; VULVAR NEOPLASMS;

EID: 84898834589     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.01.015     Document Type: Article

References (27)

1. E. Buxant, V. Anaf, and H. Haouari Rapid groin recurrence of a vulvar carcinoma with invasion of the femoral vessels and the importance of the initial groin dissection in the staging surgery Acta Chir Belg 105 2005 418 419
2. A.M. Stroup, L.C. Harlan, and E.L. Trimble Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States Gynecol Oncol 108 2008 577 583
3. SEER Cancer Statistics Factsheets: Vulvar Cancer. National Cancer Institute. Bethesda, MD. http://seer.cancer/gov/statfacts/html/vulva.html.
4. N.E. Hynes, and H.A. Lane ERBB receptors and cancer: the complexity of targeted inhibitors Nat Rev Cancer 5 2005 341 354
5. H. Brustmann Epidermal growth factor receptor is involved in the development of an invasive phenotype in vulvar squamous lesions, but is not related to MIB-1 immunoreactivity Int J Gynecol Pathol 26 2007 481 489
6. G.A. Johnson, R. Mannel, and M. Khalifa et al. Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival Gynecol Oncol 65 1997 425 429
7. M.H. Oonk, G.H. de Bock, and D.J. van der Veen et al. EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction Gynecol Oncol 104 2007 109 113
8. W.B. Growdon, S.L. Boisvert, and S. Akhavanfard et al. Decreased survival in EGFR gene amplified vulvar carcinoma Gynecol Oncol 111 2008 289 297
9. S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 2009 103 104
10. L. Woelber, S. Hess, and H. Bohlken et al. EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome J Clin Pathol 65 2012 133 139
11. N.F. Hacker, J.S. Berek, L.D. Lagasse, R.S. Leuchter, and J.G. Moore Management of regional lymph nodes and their prognostic influence in vulvar cancer Obstet Gynecol 61 1983 408 412
12. A. Berchuck, G. Rodriguez, A. Kamel, J.T. Soper, D.L. Clarke-Pearson, and R.C. Bast Jr. Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina Obstet Gynecol 76 1990 381 387
13. Y.S. Pu, C.Y. Huang, and Y.Z. Kuo et al. Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma J Biomed Sci 16 2009 82
14. S.C. Wang, and M.C. Hung Cytoplasmic/nuclear shuttling and tumor progression Ann N Y Acad Sci 1059 2005 11 15
15. C. Langner, M. Ratschek, P. Rehak, L. Schips, and R. Zigeuner Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation? J Clin Pathol 57 2004 773 775
16. A. Olawaiye, L.M. Lee, C. Krasner, and N. Horowitz Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva Gynecol Oncol 106 2007 628 630
17. S.D. Richard, T.C. Krivak, S. Beriwal, and K.K. Zorn Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab Int J Gynecol Cancer 18 2008 1132 1135
18. N.S. Horowitz, A.B. Olawaiye, and D.R. Borger et al. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva Gynecol Oncol 127 2012 141 146
19. N.J. Szerlip, A. Pedraza, and D. Chakravarty et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response Proc Natl Acad Sci U S A 109 2012 3041 3046
20. J.N. Jakobsen, E. Santoni-Rugiu, J. Ravn, and J.B. Sorensen Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer Eur J Cancer 49 2013 2494 2503
21. H. Bai, Z. Wang, and Y. Wang et al. Detection and clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with advanced non-small cell lung cancer PLoS One 8 2013 e54170
22. T.J. Grob, T. Hoenig, and T.S. Clauditz et al. Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer Lung Cancer 79 2013 221 227
23. G. Alvarez, A. Perry, B.R. Tan, and H.L. Wang Expression of epidermal growth factor receptor in squamous cell carcinomas of the anal canal is independent of gene amplification Mod Pathol 19 2006 942 949
24. Maia B. de Melo, A.M. Lavorato-Rocha, and I.S. Rodrigues et al. Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside J Transl Med 10 2012 150
25. A.M. Lavorato-Rocha, Maia B. de Melo, and I.S. Rodrigues et al. Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein Ann Surg Oncol 20 2013 31 39
26. G. Baiocchi, F.M. Cestari, and R.M. Rocha et al. Does the count after inguinofemoral lymphadenectomy in vulvar cancer correlate with outcome? Eur J Surg Oncol 39 2013 339 343
27. Maia B. de Melo, F. Munhoz Cestari, and A.M. Lavorato-Rocha et al. Characterization of sociodemographic and clinicopathological features in Brazilian patients with vulvar squamous cell carcinoma Gynecol Obstet Invest 75 2013 53 60